Validation of the modified vesikari score in children with gastroenteritis in 5 US emergency departments

Journal of Pediatric Gastroenterology and Nutrition

Volumn 57, Issue 4, 2013, Pages 514-519

  Schnadower, David ^a   Tarr, Phillip I ^a   Gorelick, Marc H ^b   O'Connell, Karen ^c   Roskind, Cindy G ^d   Powell, Elizabeth C ^e   Rao, Jayashree ^f   Bhatt, Seema ^g   Freedman, Stephen B ^h  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d New York Presbyterian Columbia University Medical Center   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALGARY   (Canada)

Author keywords

Children; Emergency department; Gastroenteritis; Severity scale; Validity

Indexed keywords

ABSENTEEISM; ACUTE GASTROENTERITIS; ARTICLE; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONSTRUCT VALIDITY; DAY CARE; DEHYDRATION; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MODIFIED VESIKARI SCORE; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; SCORING SYSTEM; VALIDATION STUDY;

ABSENTEEISM; CHILD, PRESCHOOL; DEHYDRATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84885305111     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31829ae5a3     Document Type: Article

References (39)

1. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012;379:2151-61.
2. Tate JE, Cortese MM, Payne DC, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J 2011;30:S56-60.
3. Nyachuba DG. Foodborne illness: is it on the rise? Nutr Rev 2010; 68:257-69.
4. Vital signs: incidence and trends of infection with pathogens transmitted commonly through food-foodborne diseases active surveillance network, 10 U.S. sites, 1996-2010. MMWR Morb Mortal Wkly Rep 2011;60:749-55.
5. Bruijning-Verhagen P, Sankatsing V, Kunst A, et al. Rotavirus-related hospitalizations are responsible for high seasonal peaks in all-cause pediatric hospitalizations. Pediatr Infect Dis J 2012;31:e244-9.
6. Gorelick MH, Shaw KN, Murphy KO. Validity and reliability of clinical signs in the diagnosis of dehydration in children. Pediatrics 1997;99:E6.
7. King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Morb Mortal Wkly Rep 2003;52:1-16.
8. Bartsch SM, Lopman BA, Hall AJ, et al. The potential economic value of a human norovirus vaccine for the United States. Vaccine 2012; 30:7097-104.
9. Freedman SB, Steiner M, Chan K, et al. Oral ondansetron administration in emergency departments to children with gastroenteritis: an economic analysis. PloS Med 2010;7:e1000350.
10. Dey A,Wang H, Menzies R, et al. Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program. Med J Aust 2012;197:453-7.
11. Payne DC, Staat MA, Edwards KM, et al. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US counties, 2006-2009. Clin Infect Dis 2011;53:245-53.
12. Johnston BC, Shamseer L, da Costa BR, et al. Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review. Pediatrics 2010;126:e222-31.
13. Freedman SB, Eltorky M, Gorelick M. Evaluation of a gastroenteritis severity score for use in outpatient settings. Pediatrics 2010;125: e1278-85.
14. Albano F, Szajewska H. Antiemetics for acute gastroenteritis: a never ending story. J Pediatr Gastroenterol Nutr 2006;43:546-7.
15. Freedman S, Adler M, Seshadri R, et al. Re: selected summary of "antiemetics for acute gastroenteritis: a never ending story." J Pediatr Gastroenterol Nutr 2007;45:132-3.
16. Freedman SB, Adler M, Seshadri R, et al. Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med 2006;354:1698-705.
17. van den Berg J, Berger MY. Guidelines on acute gastroenteritis in children: a critical appraisal of their quality and applicability in primary care. BMC Fam Pract 2011;12:134.
18. Clark HF, Bernstein DI, Dennehy PH, et al. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 2004;144:184-90.
19. Clark HF, Borian FE, Bell LM, et al. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 1988;158:570-87.
20. Flores J, Perez-Schael I, Gonzalez M, et al. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Lancet 1987;1:882-4.
21. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990;22:259-67.
22. A phase III clinical trial to evaluate the protective efficacy of three doses of oral rotavirus vaccine (ORV) 116E (ROTAVAC). clinicaltrials.gov/ show/NCT1305109. Accessed September 3, 2013.
23. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22.
24. Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376:615-23.
25. Glassberg JA, Wang J, Cohen R, et al. Risk factors for increased ED utilization in a multinational cohort of children with sickle cell disease. Acad Emerg Med 2012;19:664-72.
26. Li G, Lau JT, McCarthy ML, et al. Emergency department utilization in the United States and Ontario, Canada. Acad Emerg Med 2007; 14:582-4.
27. Rowe BH, Bota GW, Clark S, et al. Comparison of Canadian versus American emergency department visits for acute asthma. Can Respir J 2007;14:331-7.
28. Lasser KE, Himmelstein DU, Woolhandler S. Access to care, health status, and health disparities in the United States and Canada: results of a cross-national population-based survey. Am J Public Health 2006; 96:1300-7.
29. Goldman RD, Friedman JN, Parkin PC. Validation of the clinical dehydration scale for children with acute gastroenteritis. Pediatrics 2008;122:545-9.
30. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. New York: Oxford University Press; 2003.
31. Kline P. An Easy Guide to Factor Analysis. Padstow, England: TJ International; 1994.
32. Kaiser H. An index of factorial simplicity. Psychometrika 1974;39: 31-6.
33. Tavakol M, Dennick R. Making sense of Cronbach's alpha. Int J Med Educ 2011;2:53-5.
34. Jenkinson C. Evaluating the efficacy of medical treatment: possibilities and limitations. Soc Sci Med 1995;41:1395-401.
35. Mackenzie A, Barnes G, Shann F. Clinical signs of dehydration in children. Lancet 1989;2:605-7.
36. Pruvost I, Dubos F, Chazard E, et al. The value of body weight measurement to assess dehydration in children. PLoS One 2013; 8:e55063.
37. Sottosanti M, Morrison GC, Singh RN, et al. Dehydration in children with diabetic ketoacidosis: a prospective study. Arch Dis Child 2012;97:96-100.
38. Roland D, Clarke C, Borland ML, et al. Does a standardised scoring system of clinical signs reduce variability between doctors' assessments of the potentially dehydrated child? J Paediatr Child Health 2010; 46:103-7.
39. Sijtsma K. On the use, the misuse, and the very limited usefulness of Cronbach's alpha. Psychometrika 2009;74:107-20.